Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05758142 · ClinicalTrials.gov registry record · NA
Potassium Intake-response Trial to Control Hypertension
A NA study, sponsored by Tulane University.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05758142 is a NA study that was terminated before completion, run by Tulane University. The registered enrollment target is 25 participants.
The verdict
NCT05758142, a NA study, was terminated before completion, sponsored by Tulane University.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The Potassium Intake-response Trial to Control Hypertension (PITCH) will test the intake-response relationship between potassium supplementation and blood pressure, which may inform clinical guidelines on the optimal level of potassium supplementation for blood pressure lowering among adults with elevated blood pressure or hypertension and dietary guidelines for population intake.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Potassium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2024-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05758142
The ClinicalTrials.gov registry entry for NCT05758142 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05758142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05758142 about?
NCT05758142 is a clinical study titled "Potassium Intake-response Trial to Control Hypertension". The Potassium Intake-response Trial to Control Hypertension (PITCH) will test the intake-response relationship between potassium supplementation and blood pressure, which may inform clinical guidelines on the optimal level of potassium supplementation for blood pressure lowering among adults with el...
What is the current status of trial NCT05758142?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2023-03-29. Estimated completion is 2024-05-03.
What interventions are being tested in trial NCT05758142?
The interventions under investigation include: Placebo (OTHER), Potassium Chloride (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05758142?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.